# Marketwise, Inc.: overview MKTW · Nasdaq · CIK 1805651 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/mktw.md) · [Financials](/companies/mktw/financials.md) · [Filings](/companies/mktw/filings.md) · [Insiders](/companies/mktw/insiders.md) Latest reported revenue: [$75.8m](/filings/0001628280-26-053921.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-053921). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [97.2](/filings/0001805651-25-000008.md) | [97.5 d](/filings/0001805651-26-000016.md) | [83.5](/filings/0001805651-26-000043.md) | [80.0](/filings/0001628280-26-053921.md) | [81.3](/filings/0001805651-25-000008.md) | [83.4 d](/filings/0001805651-26-000016.md) | [77.0](/filings/0001805651-26-000043.md) | [75.8](/filings/0001628280-26-053921.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [22.5%](/filings/0001805651-25-000008.md) | [24.8% d](/filings/0001805651-26-000016.md) | [20.1%](/filings/0001805651-26-000043.md) | [18.5%](/filings/0001628280-26-053921.md) | [21.9%](/filings/0001805651-25-000008.md) | [15.8% d](/filings/0001805651-26-000016.md) | [(1.4%)](/filings/0001805651-26-000043.md) | [(5.6%)](/filings/0001628280-26-053921.md) | | Net margin | % | [1.8%](/filings/0001805651-25-000008.md) | [2.2% d](/filings/0001805651-26-000016.md) | [1.1%](/filings/0001805651-26-000043.md) | [1.6%](/filings/0001628280-26-053921.md) | [1.9%](/filings/0001805651-25-000008.md) | [2.3% d](/filings/0001805651-26-000016.md) | [(0.7%)](/filings/0001805651-26-000043.md) | [(0.8%)](/filings/0001628280-26-053921.md) | | Diluted EPS | $ per share | [0.87](/filings/0001805651-25-000008.md) | not reported | [0.41](/filings/0001805651-26-000043.md) | [0.53](/filings/0001628280-26-053921.md) | [0.58](/filings/0001805651-25-000008.md) | not reported | [(0.23)](/filings/0001805651-26-000043.md) | [(0.24)](/filings/0001628280-26-053921.md) | | Free cash flow | $m | [(5.9) d](/filings/0001805651-25-000008.md) | [5.9 d](/filings/0001805651-26-000016.md) | [1.7](/filings/0001805651-26-000043.md) | [17.7 d](/filings/0001628280-26-053921.md) | [2.2 d](/filings/0001805651-25-000008.md) | [24.0 d](/filings/0001805651-26-000016.md) | [(2.5)](/filings/0001805651-26-000043.md) | [22.3 d](/filings/0001628280-26-053921.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [549](/filings/0001628280-24-009542.md) | [512](/filings/0001628280-25-010781.md) | [448](/filings/0001805651-26-000016.md) | [409](/filings/0001805651-26-000016.md) | [328](/filings/0001805651-26-000016.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(176.2%)](/filings/0001628280-24-009542.md) | [17.0%](/filings/0001628280-25-010781.md) | [11.6%](/filings/0001805651-26-000016.md) | [21.8%](/filings/0001805651-26-000016.md) | [19.1%](/filings/0001805651-26-000016.md) | | Net margin | % | [(184.5%)](/filings/0001628280-24-009542.md) | [3.5%](/filings/0001628280-25-010781.md) | [0.4%](/filings/0001805651-26-000016.md) | [1.7%](/filings/0001805651-26-000016.md) | [1.7%](/filings/0001805651-26-000016.md) | | Diluted EPS | $ per share | not reported | [0.73](/filings/0001628280-25-010781.md) | [1.07](/filings/0001805651-26-000016.md) | [3.58](/filings/0001805651-26-000016.md) | [2.31](/filings/0001805651-26-000016.md) | | Free cash flow | $m | [63.5](/filings/0001628280-24-009542.md) | [48.3](/filings/0001628280-25-010781.md) | [62.4](/filings/0001805651-26-000016.md) | [(22.3)](/filings/0001805651-26-000016.md) | [45.6](/filings/0001805651-26-000016.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mktw/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BARCLAYS PLC](/funds/312069.md) | 2026-06-30 | $2.7m | 152,675 | | Added +875 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $2.6m | 145,952 | | Added +23,927 | | [BASS SID R](/funds/1242829.md) | 2026-06-30 | $2.6m | 145,524 | | Added +10,408 | | [Phraction Management LLC](/funds/1907803.md) | 2026-06-30 | $1.6m | 92,316 | | Reduced −6,000 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.1m | 63,973 | | Added +25 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $992.4k | 55,625 | | Added +6,383 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $587.7k | 32,943 | | Added +5,176 | | [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $572.4k | 32,085 | | Added +18,388 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $460.3k | 25,799 | | Reduced −1,375 | | [MTM Investment Management, LLC](/funds/1831416.md) | 2026-06-30 | $423.4k | 23,735 | | Added +4,531 | ## Recent filings [All 503 filings](/companies/mktw/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-24 | 08:58 ET | [8-K](/filings/0001628280-26-063325.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-063325 | | 2026-08-12 | 17:04 ET | [8-K/A](/filings/0001628280-26-056331.md) | 5.07 Shareholder vote results | 0001628280-26-056331 | | 2026-08-06 | 08:32 ET | [8-K](/filings/0001628280-26-053922.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053922 | | 2026-08-06 | 08:31 ET | [10-Q](/filings/0001628280-26-053921.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053921 | | 2026-07-10 | 17:34 ET | [8-K](/filings/0001628280-26-047817.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-047817 | | 2026-06-08 | 16:56 ET | [8-K](/filings/0001628280-26-041660.md) | 5.07 Shareholder vote results | 0001628280-26-041660 | | 2026-05-07 | 07:26 ET | [8-K](/filings/0001805651-26-000044.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001805651-26-000044 | | 2026-05-07 | 07:17 ET | [10-Q](/filings/0001805651-26-000043.md) | Quarterly report, period 2026-03-31 | 0001805651-26-000043 | | 2026-04-24 | 17:05 ET | [8-K](/filings/0001805651-26-000038.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001805651-26-000038 | | 2026-04-17 | 16:50 ET | [DEF 14A](/filings/0001805651-26-000035.md) | Proxy statement, period 2026-04-17 | 0001805651-26-000035 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001805651-26-000016.md), filed Mar 6, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/5490fe54-e3fd-4d7e-86d0-8950b1380a9c) ## About the filer - CIK: 1805651 - Tickers: MKTW - Exchange: Nasdaq - SIC code: 7372 Services-Prepackaged Software - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.